Portal vein tumor thrombosis (PVTT) in patients with hepatocellular carcinoma (HCC) is associated with a poor survival of typically less than 6 months in untreated patients (1). Click to show full abstract
Portal vein tumor thrombosis (PVTT) in patients with hepatocellular carcinoma (HCC) is associated with a poor survival of typically less than 6 months in untreated patients (1).
               
Click one of the above tabs to view related content.